Cisatracurium Besylate
These highlights do not include all the information needed to use CISATRACURIUM BESYLATE injection safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE injection. CISATRACURIUM BESYLATE injection for intravenous use. Initial U.S. Approval: 1995
Approved
Approval ID
2a68c2bc-3875-4782-820c-7dcad545ba9b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 17, 2022
Manufacturers
FDA
Piramal Healthcare UK Limited
DUNS: 345609965
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cisatracurium Besylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code24584-1112
Application NumberANDA212432
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cisatracurium Besylate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 18, 2022
FDA Product Classification
INGREDIENTS (3)
BENZENESULFONIC ACIDInactive
Code: 685928Z18A
Classification: IACT
CISATRACURIUM BESYLATEActive
Quantity: 2 mg in 1 mL
Code: 80YS8O1MBS
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
Cisatracurium Besylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code24584-1111
Application NumberANDA212432
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cisatracurium Besylate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 18, 2022
FDA Product Classification
INGREDIENTS (3)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZENESULFONIC ACIDInactive
Code: 685928Z18A
Classification: IACT
CISATRACURIUM BESYLATEActive
Quantity: 2 mg in 1 mL
Code: 80YS8O1MBS
Classification: ACTIM